At a glance
ClinicalIndex Comparison RecordN/ACompleted· 478 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China
In Brief
An observational study for Lumbar Disc Degenerative Disease. Completed, enrolled 478 participants across 10 sites.
Detailed Summary
The purpose of this study is to observe the overall satisfaction of patients with degenerative disc disease after receiving triple therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLumbar Disc Degenerative Disease
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
Primary CompletionSep 2010
Study CompletionNov 2010
First PostedFeb 2011
TodayJul 2026
First PostedFeb 18, 2011
Enrollment StartJun 1, 2010
Primary CompletionSep 1, 2010
Study CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.4 years ago